A Study to Evaluate Safety, Pharmacokinetics, and Clinical Activity of Combination of RO6870810 and Venetoclax, With or Without Rituximab, in Participants With Relapsed/Refractory DLBCL and/or High-Grade B-Cell Lymphoma and/or High Grade B-Cell Lymphoma With MYC and/or BCL2 and/or BCL6
Clinical trial NCT03255096 · COMPLETED
Trial details
- NCT number
- NCT03255096
- Sponsor
- Hoffmann-La Roche
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2017-08-28
- Primary completion
- 2019-07-03
- Enrollment
- 39
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.